|

7×19-THEMIS CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Second Affiliated Hospital, Zhejiang University, School of Medicine1

Indications

  • Transforming Follicular Lymphoma (tFL)1
  • Relapsed/Refractory Large B-cell Lymphoma (LBCL)1
  • Mantle Cell Lymphoma (MCL)1
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)1
  • Diffuse Large B-cell Lymphoma(DLBCL)1

Other1 trial

A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.